Back to results
US 12,502,395 B2Granted
Progestin/testosterone transdermal gel
AssigneesThe Population Council, Inc., The United States of America, as rep'd by the Secy., Dept. of Health and Human Services
InventorsDiana L. Blithe, Min S. Lee, Regine Sitruk-Ware
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a specific combination of a progestin and testosterone in a transdermal composition and usage thereof in a method for ensuring male contraception with more efficacy and less side effects.
Claims10
A transdermal composition in a unit dose form for contraceptive treatment of males, comprising 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione in the amount of 8.3 mg, testosterone in the amount of 73.8 mg, and a pharmaceutical acceptable excipient.
Dependencies are inferred from the claim text.